Cite
TCT-451 Use of CrossBoss in Chronic Total Occlusion Percutaneous Coronary Intervention.
MLA
Karacsonyi, Judit, et al. “TCT-451 Use of CrossBoss in Chronic Total Occlusion Percutaneous Coronary Intervention.” Journal of the American College of Cardiology (JACC), vol. 82, no. 17, Oct. 2023, pp. B181–82. EBSCOhost, https://doi.org/10.1016/j.jacc.2023.09.460.
APA
Karacsonyi, J., Rempakos, A., Alexandrou, M., Allana, S., Kostantinis, S., Simsek, B., Al-Ogaili, A., Alaswad, K., Karmpaliotis, D., Kirtane, A., McEntegart, M., Jaffer, F., Choi, J., Poommipanit, P., Elbarouni, B., Gorgulu, S., ElGuindy, A., Rafeh, N. A., Goktekin, O., & Azzalini, L. (2023). TCT-451 Use of CrossBoss in Chronic Total Occlusion Percutaneous Coronary Intervention. Journal of the American College of Cardiology (JACC), 82(17), B181–B182. https://doi.org/10.1016/j.jacc.2023.09.460
Chicago
Karacsonyi, Judit, Athanasios Rempakos, Michaella Alexandrou, Salman Allana, Spyridon Kostantinis, Bahadir Simsek, Ahmed Al-Ogaili, et al. 2023. “TCT-451 Use of CrossBoss in Chronic Total Occlusion Percutaneous Coronary Intervention.” Journal of the American College of Cardiology (JACC) 82 (17): B181–82. doi:10.1016/j.jacc.2023.09.460.